DiaPro COVID-19 IgG, IgM and IgG Confirmation Serology Assays

Dia.Pro EIA microplate kits for the detection of novel Coronavirus COVID-19 antibodies in human serum and plasma.

Dia.Pro Diagnostic Bioprobes srl, has developed and launched four new EIA microplate kits for the detection of novel Coronavirus COVID-19 antibodies in human serum and plasma.

There are two kits for the detection of either IgG or IgM to COVID-19 (nucleocapsid and spike antigens), an IgG kit for spike 1 and 2 antigens and a fourth module-based immunoassay for the confirmation and typing of IgG antibodies to COVID-19 major-antigens.

These kits have been developed and evaluated in Northern Italy and are CE marked. The assays are intended to be used to show antibody response following COVID-19 infection or for assessing antibody status of asymptomatic subjects, for example, screening Health Care workers.

Key Points

• Four assays are currently available based on EIA, 96 well, microplate technology
• All Dia.Pro COVID-19 IgG and IgM assays can be run manually or automated on an ELISA processor
• Method files are available for the Stratec Gemini, Dynex DS2 and Dynex DSX
• The confirmation assay is a modular system to individually detect antibodies against COVID-19 Spike protein 1, Spike protein 2 and Nucleocapsid
• Can be used to monitor antibody response after COVID-19 infection or to study antibody status as a screening assay.

Product Codes

• Dia.Pro COVID-19 IgG (192 tests) Ref: COV19G.CE.192
• Dia.Pro COVID-19 IgM (192 tests) Ref: COV19M.CE.192
• Dia.Pro COVID-19 Spike 1 & 2 IgG (192 tests) Ref: COV19GSPIKE.CE.192
• Dia.Pro COVID-19 IgG Confirmation (24 tests) Ref: COV19CONF.CE